CAMP

Latest SEC Filings & News for CAMP

2 most recent filings and news items mentioning CAMP. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/CAMP/news?limit=20"

Pull CAMP filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Camp4 secures TGA clearance for CMP-002 trial.

Camp4 Therapeutics received Australian regulatory approval to begin a Phase 1/2 clinical trial of CMP-002 for SYNGAP1 disorder. This milestone enables a second private offering that could raise up to $50 million.

View filing at SEC.gov →

W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday

W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.